Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women (original) (raw)

References

• Allard JP, Aghdassi E, Mohammed S, Raman M, Avand G, Arendt BM et al. (2008). Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. J Hepatol 48, 300–307.
  Article CAS Google Scholar
• Browning JD, Horton JD (2004). Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114, 147–152.
  Article CAS Google Scholar
• Capanni M, Calella F, Biagini MR, Genise S, Raimondi L, Bedogni G et al. (2006). Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther 23, 1143–1151.
  Article CAS Google Scholar
• Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C et al. (1990). NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 12, 1106–1110.
  Article Google Scholar
• Clark JM, Brancati FL, Diehl AM (2002). Nonalcoholic fatty liver disease. Gastroenterology 122, 1649–1657.
  Article Google Scholar
• Debongnie JC, Pauls C, Fievez M, Wibin E (1981). Prospective evaluation of the diagnostic accuracy of liver ultrasonography. Gut 22, 130–135.
  Article CAS Google Scholar
• Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005). Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115, 1343–1351.
  Article CAS Google Scholar
• Foster KJ, Dewbury KC, Griffith AH, Wright R (1980). The accuracy of ultrasound in the detection of fatty infiltration of the liver. Br J Radiol 53, 440–442.
  Article CAS Google Scholar
• Goessling W, Massaro JM, Vasan RS, D'Agostino Sr RB, Ellison RC, Fox CS (2008). Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology 135, 1935–1944.
  Article CAS Google Scholar
• Gore RM (1994). Diffuse liver disease. In: Gore RM, Levine MS, Laufer I. Textbook of Gastrointestinal Radiology. Saunders: Philadelphia.
  Google Scholar
• Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T et al. (2007). The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 102, 2708–2715.
  Article Google Scholar
• Itoh M, Suganami T, Satoh N, Tanimoto-Koyama K, Yuan X, Tanaka M et al. (2007). Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol 27, 1918–1925.
  Article CAS Google Scholar
• Jarrar MH, Baranova A, Collantes R, Ranard B, Stepanova M, Bennett C et al. (2007). Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 27, 412–421.
  Article Google Scholar
• Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y et al. (2005). Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 22, 1141–1145.
  Article CAS Google Scholar
• Joseph AEA, Saverymuttu SH, Al-Sam S, Cook MG, Maxwell JD (1991). Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver diseases. Clin Radiol 43, 26–31.
  Article CAS Google Scholar
• Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW et al. (2004). Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 164, 2169–2175.
  Article Google Scholar
• Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S (2003). Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol 38, 954–961.
  Article Google Scholar
• Madsen T, Skou HA, Hansen VE, Fog L, Christensen JH, Toft E et al. (2001). C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol 88, 1139–1142.
  Article CAS Google Scholar
• Nishino M, Hayakawa K, Nakamura Y, Morimoto T, Mukaihara S (2003). Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy. AJR Am J Roentgenol 180, 129–134.
  Article Google Scholar
• Perez-Matute P, Perez-Echarri N, Martinez JA, Marti A, Moreno-Aliaga MJ (2007). Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-alpha. Br J Nutr 97, 389–398.
  Article CAS Google Scholar
• Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M et al. (2002). The utility of radiological imaging in non-alcoholic fatty liver disease. Gastroenterology 123, 745–750.
  Article Google Scholar
• Sasaki S (2004). Development and evaluation of dietary assessment methods using biomarkers and diet history questionnaires for individuals. (head investigator: Tanaka H) Research for Evaluation Methods of Nutrition and Dietary Lifestyle Programs held on Healthy Japan 21. Summary Report of the Ministry of Health, Labour and Warfare. Ministry of Health, Labour and Warfare: Japan, pp 10–44 (in Japanese).
  Google Scholar
• Sasaki S, Yanagibori R, Amano K (1998). Self-administered diet history questionnaire developed for health education: a relative validation of the test-version by comparison with 3-day diet record in women. J Epidemiol 8, 203–215.
  Article CAS Google Scholar
• Saverymuttu SH, Joseph AEA, Maxwell JD (1986). Ultrasound scanning in the detection of hepatic fibrosis and steatosis. BMJ 292, 13–15.
  Article CAS Google Scholar
• Schwarz JM, Neese RA, Turner S, Dare D, Hellerstein MK (1995). Short-term alterations in carbohydrate energy intake in humans. J Clin Invest 96, 2735–2743.
  Article CAS Google Scholar
• Sessler AM, Ntambi JM (1998). Polyunsaturated fatty acid regulation of gene expression. J Nutr 128, 923–926.
  Article CAS Google Scholar
• Solga S, Alkhuraishe AR, Clark JM, Torbenson M, Greenwald A, Diehl AM et al. (2004). Dietary composition and nonalcoholic fatty liver disease. Dig Dis Sci 49, 1578–1583.
  Article Google Scholar
• Spadaro L, Magliocco O, Spampinato D, Piro S, Oliveri C, Alagona C et al. (2008). Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis 40, 194–199.
  Article CAS Google Scholar
• Sugano M, Hirahara F (2000). Polyunsaturated fatty acids in the food chain in Japan. Am J Clin Nutr 71 (Suppl), S189–S196.
  Article Google Scholar
• Tanaka N, Sano K, Horiguchi A, Tanaka E, Kiyosawa K, Aoyama T (2008). Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol 42, 413–418.
  Article CAS Google Scholar
• Targher G (2007). Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med 24, 1–6.
  Article CAS Google Scholar
• The Japan Society of Hepatology (2006). Guideline for treatment of NASH/NAFLD. In: Okaue T (ed). Bunkodo: Tokyo. pp 40–47 (in Japanese).
• Vega GL, Chandalia M, Szczepaniak LS, Grundy SM (2008). Effects of n-3 fatty acids on hepatic triglyceride content in humans. J Investig Med 56, 780–785.
  Article CAS Google Scholar
• Weston SR, Leyden W, Murphy R, Bass NM, Bell BP, Manos MM et al. (2005). Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 41, 372–379.
  Article Google Scholar
• Yamazaki T, Nakamori A, Sasaki E, Wada S, Ezaki O (2007). Fish oil prevents sucrose-induced fatty liver but exacerbates high-safflower oil-induced fatty liver in ddY mice. Hepatology 46, 1779–1790.
  Article CAS Google Scholar
• Yoshikawa T, Shimano H, Yahagi N, Ide T, Matsuzaka T, Nakakuki M et al. (2002). Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem 277, 1705–1711.
  Article CAS Google Scholar
• Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Blendis L, Halpern Z et al. (2007). Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study. J Hepatol 47, 711–717.
  Article CAS Google Scholar

Download references